1、2015 ANNUAL REPORTON FORM 10-K2016 NOTICE OFANNUAL MEETING ANDPROXY STATEMENTPEOPLE.PASSION.POSSIBILITIES.AbbVie1 North Waukegan RoadNorth Chicago,IL 60064 U.S.ACopyright 2016 AbbVie.All rights reserved.stockholder informationAbbVie Inc.Corporate Headquarters1 North Waukegan RoadNorth Chicago,IL Inv
2、estor RelationsDept.ZZ05,AP34Corporate SecretaryDept.V364,AP34Stock ListingThe ticker for AbbVies common stockis ABBV.The principal market for AbbViecommon stock is the NYSE.AbbViecommon stock is also listed on the ChicagoStock Exchange,the NYSE Euronext Paris,and the SIX Swiss Exchange.Annual Meeti
3、ngThe Annual Meeting will be held onFriday,May 6,2016,at 9 AM atthe Fairmont Chicago,Millennium Park,200 North Columbus Drive,Chicago,IL 60601.Dividend Reinvestment PlanThe AbbVie Dividend ReinvestmentPlan ofers registered stockholders an opportunity to purchase additionalshares,commission-free,thro
4、ughautomatic dividend reinvestmentand/or optional cash investments.Interested persons may contact thetransfer agent.Transfer AgentComputershare Trust Co.NAP.O.Box 43078Providence,RI 02940-3078877.881.5970(toll free)about abbvieAbbVie is a global,research-based biopharmaceutical company formed in 201
5、3 following separation from Abbott Laboratories.The companys mission is to use its expertise,dedicated people,and unique approach to innovation to develop and market advanced therapies that address some of the worlds most complex and serious diseases.Together with its wholly-owned subsidiary,Pharmac
6、yclics,AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.For further information on the company and its people,portfolio,and commitments,please visit .Printed on recycled paper13NOV2012213657664DEC201212233206Dear AbbVie Shareholder:2015 was another ou